These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23796286)

  • 21. A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure.
    Postmus D; Pari AA; Jaarsma T; Luttik ML; van Veldhuisen DJ; Hillege HL; Buskens E
    Am Heart J; 2011 Dec; 162(6):1096-104. PubMed ID: 22137084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the approach to parameter uncertainty in early economic evaluations of surgical technology - a systematic review.
    Browne IL; Zhang W; Sutton AJ
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jan; 23(1):29-41. PubMed ID: 36357336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HEADROOM BEYOND THE QUALITY- ADJUSTED LIFE-YEAR: THE CASE OF COMPLEX PEDIATRIC NEUROLOGY.
    van Nimwegen KJM; Lilford RJ; van der Wilt GJ; Grutters JPC
    Int J Technol Assess Health Care; 2017 Jan; 33(1):5-10. PubMed ID: 28554333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Belief elicitation to populate health economic models of medical diagnostic devices in development.
    Haakma W; Steuten LM; Bojke L; IJzerman MJ
    Appl Health Econ Health Policy; 2014 Jun; 12(3):327-34. PubMed ID: 24623041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS.
    Akpinar I; Jacobs P; Husereau D
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):86-9. PubMed ID: 25989920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of benefit and efficiency of innovative medical devices].
    Perleth M; Lühmann D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):825-30. PubMed ID: 20700782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of probabilistic methods in economic evaluation of health technologies].
    Darbà J
    Gac Sanit; 2006; 20(1):74-7. PubMed ID: 16539999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Discrete-event simulation models in the economic evaluation of health technologies and health products].
    Rodríguez Barrios JM; Serrano D; Monleón T; Caro J
    Gac Sanit; 2008; 22(2):151-61. PubMed ID: 18420015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Decision modeling for economic evaluation of health technologies].
    de Soárez PC; Soares MO; Novaes HM
    Cien Saude Colet; 2014 Oct; 19(10):4209-22. PubMed ID: 25272129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions.
    Frederix GW; Haji Ali Afzali H; Dasbach EJ; Ward RL
    Pharmacoeconomics; 2015 Aug; 33(8):777-81. PubMed ID: 25827099
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical equipment replacement plan puts budget spotlight on bedside technologies.
    Williams JS
    Biomed Instrum Technol; 2010; 44(6):478-81. PubMed ID: 21142512
    [No Abstract]   [Full Text] [Related]  

  • 32. Headroom Analysis for Early Economic Evaluation: A Systematic Review.
    Boudewijns EA; Otten TM; Gobianidze M; Ramaekers BL; van Schayck OCP; Joore MA
    Appl Health Econ Health Policy; 2023 Mar; 21(2):195-204. PubMed ID: 36575333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using probability boxes to model elicited information: a case study.
    Roelofs VJ; Roelofs W
    Risk Anal; 2013 Sep; 33(9):1650-60. PubMed ID: 23231722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of health care technologies for the developing world.
    Malkin RA
    Annu Rev Biomed Eng; 2007; 9():567-87. PubMed ID: 17430083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constructing a state-transition model for an economic evaluation of cancer treatments.
    Limwattananon C; Limwattananon S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S108-12. PubMed ID: 24964707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.
    Grigore B; Peters J; Hyde C; Stein K
    BMC Med Inform Decis Mak; 2017 Sep; 17(1):131. PubMed ID: 28870196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving healthcare through advances in point-of-care technologies.
    Kazmierczak S
    Clin Chem Lab Med; 2008; 46(1):1-2. PubMed ID: 18194080
    [No Abstract]   [Full Text] [Related]  

  • 38. Reference Case Methods for Expert Elicitation in Health Care Decision Making.
    Bojke L; Soares MO; Claxton K; Colson A; Fox A; Jackson C; Jankovic D; Morton A; Sharples LD; Taylor A
    Med Decis Making; 2022 Feb; 42(2):182-193. PubMed ID: 34271832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Health Economic Modelling - Optimizing Development for Medical Device Developers? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".
    Teljeur C; Ryan M
    Int J Health Policy Manag; 2020 Sep; 9(9):403-405. PubMed ID: 32610765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An approach to quantify parameter uncertainty in early assessment of novel health technologies.
    Iskandar R; Federici C; Berns C; Blankart CR
    Health Econ; 2022 Sep; 31 Suppl 1():116-134. PubMed ID: 35581685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.